Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Corcept Therapeutics (CORT) Times Interest Earned (2016 - 2017)

Corcept Therapeutics (CORT) has disclosed Times Interest Earned for 7 consecutive years, with $130.56 as the latest value for Q2 2017.

  • For Q2 2017, Times Interest Earned rose 4497.35% year-over-year to $130.56; the TTM value through Mar 2018 reached $705.2, up 8036.4%, while the annual FY2016 figure was $4.99, 529.91% up from the prior year.
  • Times Interest Earned hit $130.56 in Q2 2017 for Corcept Therapeutics, up from $21.07 in the prior quarter.
  • Across five years, Times Interest Earned topped out at $130.56 in Q2 2017 and bottomed at -$12.01 in Q1 2014.
  • Average Times Interest Earned over 5 years is $6.47, with a median of -$1.51 recorded in 2015.
  • Year-over-year, Times Interest Earned dropped 25.19% in 2014 and then skyrocketed 4497.35% in 2017.
  • Corcept Therapeutics' Times Interest Earned stood at -$9.17 in 2013, then soared by 58.97% to -$3.76 in 2014, then surged by 163.43% to $2.39 in 2015, then skyrocketed by 411.86% to $12.21 in 2016, then soared by 969.11% to $130.56 in 2017.
  • According to Business Quant data, Times Interest Earned over the past three periods came in at $130.56, $21.07, and $12.21 for Q2 2017, Q1 2017, and Q4 2016 respectively.